Additional file 1: of ALAIN01â Alemtuzumab in autoimmune inflammatory neurodegeneration: mechanisms of action and neuroprotective potentialTobias Ruck, Ali Afzali, Karl-Friedrich Lukat, Maria Eveslage, Catharina Gross, Steffen Pfeuffer, Stefan Bittner, Luisa Klotz, Nico Melzer, Heinz Wiendl & Sven Meuth
Assessment Schedule. (DOCX 42Â kb)
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.